These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3457780)

  • 21. A phase II study of oral weekly 4-demethoxydaunorubicin in advanced breast cancer.
    Smith DB; Howell A
    Eur J Cancer Clin Oncol; 1987 Apr; 23(4):391-4. PubMed ID: 3475204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II evaluation of orally administered idarubicin in patients with advanced breast cancer.
    Casper ES; Raymond V; Hakes TB; Currie VE; Kaufman RJ
    Cancer Treat Rep; 1987 Dec; 71(12):1289-90. PubMed ID: 3480045
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society.
    Possinger K; Wagner H; Worst P; Queisser W; Bremer K; Rieche K; Klee M; Westerhausen M; Donhuijsen-Ant R; Fritze D
    Onkologie; 1991 Feb; 14(1):31-4. PubMed ID: 2057172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study.
    Kolarić K; Mechl Z
    Oncology; 1991; 48(2):93-6. PubMed ID: 1997944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of oral idarubicin in elderly patients with advanced breast cancer.
    Chevallier B; Monnier A; Metz R; Namer M; Marty M; Roche H; Bastit P; Hurteloup P
    Am J Clin Oncol; 1990 Oct; 13(5):436-9. PubMed ID: 2220664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses.
    Kaplan S; Sessa C; Willems Y; Pacciarini MA; Tamassia V; Cavalli F
    Invest New Drugs; 1984; 2(3):281-6. PubMed ID: 6595240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies.
    Ganzina F; Pacciarini MA; Di Pietro N
    Invest New Drugs; 1986; 4(1):85-105. PubMed ID: 3516918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I clinical evaluation of oral and intravenous 4-demethoxydaunorubicin.
    Kavanagh JJ; Yeung KY; Savaraj N; Krakoff IH
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1187-9. PubMed ID: 3865774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemia.
    Hayat M; Hurteloup P; Parmentier C; Carde P; Pico JO; Schlumberger M; Chahine G; Kamioner D
    Invest New Drugs; 1984; 2(4):375-9. PubMed ID: 6595242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer.
    Rozencweig M; ten Bokkel Huinink W; Cavalli F; Bruntsch U; Dombernowsky P; Høst H; Bramwell V; Renard G; Van Glabbeke M; Decoster G
    J Clin Oncol; 1984 Apr; 2(4):275-81. PubMed ID: 6584561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral idarubicin in the treatment of advanced breast cancer.
    Bastholt L; Dalmark M; Jakobsen A; Gadeberg CC; Sandberg E; Mouridsen HT
    Acta Oncol; 1989; 28(6):893-7. PubMed ID: 2611039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive days.
    Dodion P; de Valeriola D; Crespeigne N; Peeters B; Wery F; van Berchem C; Piccart M; Tueni E; Joggi J; Kenis Y
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1019-26. PubMed ID: 2970391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous administration of cyclophosphamide, methotrexate and 5-fluorouracil in metastatic breast cancer. A pilot study.
    De Lena M; Brandi M; Logroscino A; Lorusso V; Paradiso A; Maiello E
    Tumori; 1988 Feb; 74(1):57-63. PubMed ID: 3162624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of idarubicin in advanced endometrial carcinoma.
    Hakes TB; Raymond V
    Cancer Treat Rep; 1987 May; 71(5):535-6. PubMed ID: 3471330
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II study of intravenous menogaril in patients with advanced breast cancer.
    Sessa C; Gundersen S; ten Bokkel Huinink W; Renard J; Cavalli F
    J Natl Cancer Inst; 1988 Sep; 80(13):1066-9. PubMed ID: 2970554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II trial of oral 4'demethoxydaunorubicin in advanced colorectal carcinoma.
    Presgrave P; Woods R; Dalley D; Bell D; Levi J
    Am J Clin Oncol; 1988 Oct; 11(5):564-5. PubMed ID: 3177259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer.
    Berman E; Wittes RE; Leyland-Jones B; Casper ES; Gralla RJ; Howard J; Williams L; Baratz R; Young CW
    Cancer Res; 1983 Dec; 43(12 Pt 1):6096-101. PubMed ID: 6580068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I clinical trial of orally administered 4-demethoxydaunorubicin (idarubicin) with pharmacokinetic and in vitro drug sensitivity testing in children with refractory leukemia.
    Pui CH; de Graaf SS; Dow LW; Rodman JH; Evans WE; Alpert BS; Murphy SB
    Cancer Res; 1988 Sep; 48(18):5348-52. PubMed ID: 3165708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral idarubicin in non-Hodgkin's lymphomas.
    Lopez M; Di Lauro L; Papaldo P
    Invest New Drugs; 1986; 4(3):263-7. PubMed ID: 3469170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma.
    Case DC; Hayes DM; Gerber M; Gams R; Ervin TJ; Dorsk BM
    Cancer Res; 1990 Nov; 50(21):6833-5. PubMed ID: 2208149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.